The recent outbreak of meningitis in the US — and the subsequent deaths of 15 individuals — has renewed scrutiny on the contemporary practice of pharmacy compounding. The risks to patients, and associated liability risk to prescribing physicians, largely outweigh the benefits when the practice goes beyond the traditional, extemporaneous role, according to experts.